{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:55Z","timestamp":1787020195369,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100030902","name":"Martin-Luther-Universit\u00e4t Halle-Wittenberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100030902","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Managing acute myocardial infarction (AMI) in patients with chronic kidney disease (CKD) or end-stage renal disease on dialysis (renal replacement therapy, RRT) presents challenges due to elevated complication risks. Concerns about contrast-related kidney damage may lead to the omission of guideline-directed therapies like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed German-DRG data of 2016 provided by the German Federal Bureau of Statistics (DESTATIS). We included cases with a primary diagnosis of AMI (ST-Elevation Myocardial Infarction (STEMI) or Non-ST-Elevation Myocardial Infarction (NSTEMI) ICD-10: I21 or I22) with and without CKD or RRT. We calculated crude- and age-standardized hospitalization rates (ASR, per 100,000 person years). Furthermore, we calculated log-binominal regression models adjusting for sex, CKD, RRT, comorbidities, and place of residence to estimate adjusted relative-risks (aRR) for receiving treatments of interest in AMI, such as PCI or CABG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 217,514 AMI-cases (69,728 STEMI-cases and 147,786 NSTEMI-cases). AMI-cases without CKD had percutaneous coronary intervention (PCI) in 60.8%. In contrast, AMI-cases with CKD or RRT had PCI in 46.6% and 54.5%, respectively. The ASR for AMI-cases amounted to 184.7 (95%CI 183.5-185.8) per 100,000 person years. In regression analysis AMI-cases with CKD were less likely treated with PCI (aRR: 0.89 (95%CI 0.88\u20130.90)), compared to cases without CKD. AMI-Cases with RRT showed no difference in PCI rates (aRR: 1.0 (95%CI 0.97\u20131.03)) but were more frequently treated with CABG (aRR: 2.20 (95%CI 2.03\u20132.39)). Conversely, CKD was negatively associated with CABG (aRR: 0.71, 95%CI 0.67\u20130.75) when non-CKD cases were used as the reference group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We show that AMI-cases with CKD underwent PCI less frequently, while RRT has no discernible impact on PCI utilization in AMI. Furthermore, AMI-cases with RRT exhibited a higher CABG rate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-025-03943-5","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T10:02:02Z","timestamp":1736416922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Management of acute myocardial infarction in chronic kidney disease in Germany: an observational study"],"prefix":"10.1186","volume":"26","author":[{"given":"Victor","family":"Walendy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Girndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"3943_CR1","doi-asserted-by":"publisher","first-page":"E801","DOI":"10.1002\/ccd.29436","volume":"97","author":"JE Bloom","year":"2021","unstructured":"Bloom JE, Dinh DT, Noaman S, et al. Adverse impact of chronic kidney disease on clinical outcomes following percutaneous coronary intervention. Catheter Cardiovasc Interv. 2021;97:E801\u20139.","journal-title":"Catheter Cardiovasc Interv"},{"key":"3943_CR2","doi-asserted-by":"publisher","unstructured":"Lautam\u00e4ki A, Kiviniemi T, Biancari F et al. Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b-5 chronic kidney disease. 2015. https:\/\/doi.org\/10.1093\/ejcts\/ezv233","DOI":"10.1093\/ejcts\/ezv233"},{"key":"3943_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2016.11.026","volume":"227","author":"NR Smilowitz","year":"2017","unstructured":"Smilowitz NR, Gupta N, Guo Y, et al. Management and outcomes of acute myocardial infarction in patients with chronic kidney disease. Int J Cardiol. 2017;227:1\u20137.","journal-title":"Int J Cardiol"},{"key":"3943_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00134-022-06966-w","volume":"49","author":"MR Ehmann","year":"2023","unstructured":"Ehmann MR, Mitchell J, Levin S, et al. Renal outcomes following intravenous contrast administration in patients with acute kidney injury: a multi-site retrospective propensity-adjusted analysis. Intensive Care Med. 2023;49:205\u201315.","journal-title":"Intensive Care Med"},{"key":"3943_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00134-017-4700-9","volume":"43","author":"S Ehrmann","year":"2017","unstructured":"Ehrmann S, Quartin A, Hobbs BP, et al. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. 2017;43:785\u201394.","journal-title":"Intensive Care Med"},{"key":"3943_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1681\/ASN.2016010021","volume":"28","author":"E Wilhelm-Leen","year":"2017","unstructured":"Wilhelm-Leen E, Montez-Rath ME, Chertow G. Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol. 2017;28:653\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"3943_CR7","doi-asserted-by":"publisher","unstructured":"Weisbord SD, Mor MK, Hochheiser H, et al. Utilization and outcomes of clinically indicated invasive cardiac care in veterans with acute coronary syndrome and chronic kidney disease. J Am Soc Nephrol. 2023;34. https:\/\/doi.org\/10.1681\/ASN.0000000000000067","DOI":"10.1681\/ASN.0000000000000067"},{"key":"3943_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000450834","volume":"44","author":"A Sakhuja","year":"2016","unstructured":"Sakhuja A, Wright RS, Schold JD, et al. National impact of maintenance dialysis or renal transplantation on outcomes following ST elevation myocardial infarction. Am J Nephrol. 2016;44:329\u201338.","journal-title":"Am J Nephrol"},{"key":"3943_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ahj.2011.12.002","volume":"163","author":"GR Shroff","year":"2012","unstructured":"Shroff GR, Frederick PD, Herzog CA. Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System\/National Institutes o. Am Heart J. 2012;163:399\u2013406.","journal-title":"Am Heart J"},{"key":"3943_CR10","doi-asserted-by":"crossref","unstructured":"Windecker S, Kolh P, Alfonso F et al. 2014 ESC\/EACTS Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541\u2013619.","DOI":"10.1093\/eurheartj\/ehu278"},{"key":"3943_CR11","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"J-P Collet","year":"2021","unstructured":"Collet J-P, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation the task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2021;42:1289\u2013367.","journal-title":"Eur Heart J"},{"key":"3943_CR12","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1053\/j.ajkd.2021.08.023","volume":"79","author":"A Kawsara","year":"2022","unstructured":"Kawsara A, Sulaiman S, Mohamed M, et al. Treatment effect of percutaneous coronary intervention in dialysis patients with ST-elevation myocardial infarction. Am J Kidney Dis. 2022;79:832\u201340.","journal-title":"Am J Kidney Dis"},{"key":"3943_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.amjmed.2010.04.025","volume":"123","author":"PA Santolucito","year":"2010","unstructured":"Santolucito PA, Tighe DA, McManus DD, et al. Management and outcomes of renal disease and acute myocardial infarction. Am J Med. 2010;123:847\u201355.","journal-title":"Am J Med"},{"key":"3943_CR14","doi-asserted-by":"publisher","unstructured":"Walendy V, Stang A. Clinical management of unruptured intracranial aneurysm in Germany: a nationwide observational study over a 5-year period (2005\u20132009). BMJ Open. 2017;7. https:\/\/doi.org\/10.1136\/bmjopen-2016-012294","DOI":"10.1136\/bmjopen-2016-012294"},{"key":"3943_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000355843","volume":"42","author":"V Walendy","year":"2014","unstructured":"Walendy V, Strauss C, Rachinger J, et al. Treatment of aneurysmal subarachnoid haemorrhage in Germany: a nationwide analysis of the years 2005\u20132009. Neuroepidemiology. 2014;42:90\u20137.","journal-title":"Neuroepidemiology"},{"key":"3943_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"3943_CR17","unstructured":"Pace Monica C, Elodie A, Lucian, et al. Revision of the European Standard Population: report of Eurostat\u2019s Task Force: 2013 Edition. Publications Office; 2013."},{"key":"3943_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/(SICI)1097-0258(19970415)16:7<791::AID-SIM500>3.0.CO;2-#","volume":"16","author":"MP Fay","year":"1997","unstructured":"Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med. 1997;16:791\u2013801.","journal-title":"Stat Med"},{"key":"3943_CR19","doi-asserted-by":"publisher","unstructured":"Tennant PW, Murray EJ, Arnold KF et al. Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations., https:\/\/doi.org\/10.1093\/ije\/dyaa213","DOI":"10.1093\/ije\/dyaa213"},{"key":"3943_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/ndt\/15.2.218","volume":"15","author":"U Schwarz","year":"2000","unstructured":"Schwarz U, Buzello M, Ritz E, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dialysis Transplantation. 2000;15:218\u201323.","journal-title":"Nephrol Dialysis Transplantation"},{"key":"3943_CR21","doi-asserted-by":"publisher","unstructured":"Kerr AJ, Choi YC, Pilmore HL. Invasive management and outcomes in acute coronary syndromes and chronic kidney disease (ANZACS-QI 70). Heart Lung Circ. 2023;32. https:\/\/doi.org\/10.1016\/J.HLC.2023.04.294","DOI":"10.1016\/J.HLC.2023.04.294"},{"key":"3943_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-022-02573-1","volume":"22","author":"J Schmucker","year":"2022","unstructured":"Schmucker J, Fach A, Osteresch R, et al. Temporal trends in treatment strategies and clinical outcomes among patients with advanced chronic kidney disease and ST-elevation myocardial infarctions: results from the Bremen STEMI registry. BMC Cardiovasc Disord. 2022;22:1\u201312.","journal-title":"BMC Cardiovasc Disord"},{"key":"3943_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.119.015084","volume":"9","author":"MJ Holzmann","year":"2020","unstructured":"Holzmann MJ, Siddiqui AJ. Outcome of percutaneous coronary intervention during non\u2013St-segment\u2013 elevation myocardial infarction in elderly patients with chronic kidney disease. J Am Heart Assoc. 2020;9:1\u20138.","journal-title":"J Am Heart Assoc"},{"key":"3943_CR24","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","volume":"39","author":"PJM Best","year":"2002","unstructured":"Best PJM, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002;39:1113\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"3943_CR25","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1097\/01.ASN.0000135969.33773.0B","volume":"15","author":"GM Chertow","year":"2004","unstructured":"Chertow GM, Normand SLT, McNeil BJ. Renalism: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol. 2004;15:2462\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"3943_CR26","doi-asserted-by":"publisher","unstructured":"Holzmann MJ, Siddiqui AJ. Outcome of percutaneous coronary intervention during non\u2013St-segment\u2013 elevation myocardial infarction in elderly patients with chronic kidney disease. J Am Heart Assoc. 2020;9. https:\/\/doi.org\/10.1161\/JAHA.119.015084","DOI":"10.1161\/JAHA.119.015084"},{"key":"3943_CR27","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1161\/CIRCULATIONAHA.112.001264","volume":"127","author":"GR Shroff","year":"2013","unstructured":"Shroff GR, Solid CA, Herzog CA. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation. 2013;127:1861\u20139.","journal-title":"Circulation"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-03943-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-03943-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-03943-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T11:02:46Z","timestamp":1736420566000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-03943-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3943"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-03943-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The approval of an ethics committee was not obtained because the authors were using anonymized data supplied by the German Federal Bureau of Statistics (DESTATIS). The anonymization of such data is regulated in \u00a7\u00a016 Bundesstatistikgesetz (Federal Statistics Act).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Dr. Girndt reports lecture fees from Amgen, Astellas, Bayer Vital, Daiichi.Sankyo, Hexal, Sanofi, Vifor, outside the submitted work; He is engaged in complimentary work for the Commission for Hygiene and Infection Prevention,German Society of Nephrology and as Member of the Board of the German Society for Applied Hygiene in Dialysis.Dr. Walendy received a lecture fee from Bayer Pharmaceuticals and received financial support for congress costs from Lilly Pharma Germany.Dr. Stang has nothing to disclose.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}],"article-number":"15"}}